CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it reported its consolidated financial results for the quarter and year ended December 31, 2007, and also commented on certain other recent corporate accomplishments and plans.
